LMO7 Antikörper (AA 453-540)
(1 reference)-
- Target Alle LMO7 Antikörper anzeigen
- LMO7 (LIM Domain 7 (LMO7))
-
Bindungsspezifität
- AA 453-540
-
Reaktivität
- Human
-
Wirt
- Maus
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser LMO7 Antikörper ist unkonjugiert
-
Applikation
- Western Blotting (WB), ELISA
- Verwendungszweck
- Mouse polyclonal antibody raised against a partial recombinant LMO7.
- Sequenz
- DRESQNQKST VPSRRRMYSF DDVLEEGKRP PTMTVSEASY QSERVEEKGA TYPSEIPKED STTFAKREDR VTTEIQLPSQ SPVEEQSP
- Kreuzreaktivität
- Human
- Produktmerkmale
- Antibody Reactive Against Recombinant Protein.
- Immunogen
- LMO7 (NP_005349, 453 a.a. ~ 540 a.a) partial recombinant protein with GST tag.
- Top Product
- Discover our top product LMO7 Primärantikörper
-
anti-LIM Domain 7 (LMO7) (AA 1301-1465) antibody
LMO7 Reaktivität: Human ELISA, IF, IHC Wirt: Kaninchen Polyclonal unconjugated
anti-LIM Domain 7 (LMO7) (C-Term) antibodyLMO7 Reaktivität: Human WB, ELISA, IHC Wirt: Kaninchen Polyclonal unconjugated
anti-LIM Domain 7 (LMO7) (AA 1407-1440), (C-Term) antibodyLMO7 Reaktivität: Human WB Wirt: Kaninchen Polyclonal RB52642 unconjugated
anti-LIM Domain 7 (LMO7) (AA 616-644) antibodyLMO7 Reaktivität: Human WB Wirt: Kaninchen Polyclonal RB41024 unconjugated
anti-LIM Domain 7 (LMO7) (AA 453-540) antibodyLMO7 Reaktivität: Human ELISA, IF Wirt: Maus Monoclonal 4B4 unconjugated
anti-LIM Domain 7 (LMO7) (Internal Region) antibodyVerified LMO7 Reaktivität: Human WB, ELISA Wirt: Ziege Polyclonal unconjugated
-
- Applikationshinweise
- Optimal working dilution should be determined by the investigator.
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Buffer
- 50 % glycerol
- Handhabung
- Aliquot to avoid repeated freezing and thawing.
- Lagerung
- -20 °C
- Informationen zur Lagerung
- Store at -20°C or lower. Aliquot to avoid repeated freezing and thawing.
-
-
: "LMO7 mediates cell-specific activation of the Rho-myocardin-related transcription factor-serum response factor pathway and plays an important role in breast cancer cell migration." in: Molecular and cellular biology, Vol. 31, Issue 16, pp. 3223-40, (2011) (PubMed).
-
: "LMO7 mediates cell-specific activation of the Rho-myocardin-related transcription factor-serum response factor pathway and plays an important role in breast cancer cell migration." in: Molecular and cellular biology, Vol. 31, Issue 16, pp. 3223-40, (2011) (PubMed).
-
- Target
- LMO7 (LIM Domain 7 (LMO7))
- Andere Bezeichnung
- LMO7 (LMO7 Produkte)
- Synonyme
- Gm914 antikoerper, C78582 antikoerper, FBXO20 antikoerper, mKIAA0858 antikoerper, lmo7 antikoerper, zgc:152922 antikoerper, FBX20 antikoerper, LOMP antikoerper, LIM domain 7 antikoerper, LIM domain 7 protein L homeolog antikoerper, LIM domain 7 protein antikoerper, LIM domain only 7 antikoerper, LIM domain 7b antikoerper, Lmo7 antikoerper, lmo7.L antikoerper, lmo7 antikoerper, lmo7b antikoerper, LMO7 antikoerper
- Hintergrund
-
Full Gene Name: LIM domain 7
Synonyms: FBX20,FBXO20,KIAA0858,LOMP - Gen-ID
- 4008
- NCBI Accession
- NM_005358
-
